Register to chat with like-minded investors on our interactive forums.
The current CYTO market cap is 1.02M. The company's latest EPS is CHF -1.1374 and P/E is -2.67.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 0 | 0 | 64k | 306k | 158k |
| Operating Income | -7.26M | -5.5M | -17.1M | -26.13M | -7.73M |
| Net Income | -6.63M | -8.2M | -17.39M | -26.53M | -3.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 9.23M | 20.8M | 18.84M | 6.3M | 7.69M |
| Total Liabilities | 3.19M | 4.03M | 6.13M | 14.62M | 1.24M |
| Total Equity | 6.04M | 16.77M | 12.71M | -8.32M | 6.46M |
| Market Cap | 1.02M |
| Price to Earnings Ratio | -2.67 |
| Price to Sales Ratio | 65.52 |
| Price to Cash Ratio | 16.76 |
| Price to Book Ratio | 1.6 |
| Dividend Yield | - |
| Shares Outstanding | 3.4M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -82.25% |
| 52 Week High | 3.49 |
| 52 Week Low | 0.30 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Altamira Therapeutics Ltd |
| Address |
dornacherstrasse 210 basel 4053 |
| Website | https://altamiratherapeutics.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
